Table 1. Study and Population Characteristics.
| Study | BPPV | Treatment | Control Group | |||||
|---|---|---|---|---|---|---|---|---|
| Author | Design | n (F/M) | Canal (n) | Age, Mean ± SD, y | PRM | Follow-up | n (F/M) | Age, Mean ± SD, y |
| Balci and Akdal26 | Prospective | 57 (41/16) | PC | 51.45 ± 13.29 | Epley | 1 wk 1 mo |
||
| Çelebisoy et al27 | Prospective | 44 | PC (32) LC (12) |
55 (range 32-77) 55.6 (range 39-74) |
Modified Epley BBQ |
1 wk/2 wk | 50 | 48.3 (range 27-70) |
| Chang et al38 | Randomized controlled trial | 13 (7/6) | PC | 53.93 ± 9.97 | Modified Epley | 2 wk/4 wk | ||
| Cohen et al39 | Prospective | 21 (11/10) | PC + LC (13) | 58.8 ± 11.7 | 61 (30/31) | 49.6 ± 16.0 | ||
| Cohen-Shwartz et al40 | Prospective | 32 (25/7) | PC | 64.3 ± 6.4 | Epley | 1 wk | 15 (9/6) | 63.5 ± 7.1 |
| D'Silva et al41 | Prospective | 34 (29/5) | PC | 58.85 ± 10.65 | Unclear | 7-10 d | ||
| Ganança et al46 | Retrospective | 121 (71/50) | PC (100) LC (16) AC (4) |
Range 65-89 | Epley BBQ |
12 mo | ||
| Huang et al42 | Retrospective | 255 (178/77) | Unclear | 65.4 ± 12.0 | 295 (159/136) | 59.1 ± 17.7 | ||
| Jumani and Powell47 | Retrospective | 40 (27/13) | PC (39) AC (1) |
>65 y | Epley Reverse Epley |
6 mo | ||
| Jung et al48 | Randomized controlled trial | 34 (21/13) | PC (14) LC (12) AC (3) |
53 | Epley Rahko's BBQ |
After confirming resolution of nystagmus | ||
| Kollén et al43 | Prospective | 17 (13/4) | PC | 52 (range: 31-66) | Sémont | 1 mo/6 mo/12 mo | ||
| Kollén et al44 | Prospective | 63 (46/17) | PC | 75 | 508 (286/222) | 75 | ||
| Lim et al45 | Prospective | 33 (23/11) | PC (24) LC (10) |
60.20 ± 11.94 | Epley BBQ Gufoni |
Mean: 8.73 d (SD: 5.94) |
||
| Lindell et al28 | Prospective, cross-sectional | 11 (8/3) | Unclear | 75 | 403 (224/179) | 75 | ||
| Lindell et al29 | Prospective | 15 (14/1) | PC (10) LC (5) |
79 ± 3.8 | 40 (38/2) | 78 ± 4.5 | ||
| Hawke et al49 | Prospective | 18 | Unclear | 69 ± 13 | 16 | 69 ± 13 | ||
| Oghalai et al30 | Cross-sectional | 9 | Unclear | 74 ± 1 | 91 | Unclear | ||
| Se To et al31 | Randomized controlled trial | 14 (13/1) | PC | 54.36 ± 8.55 | Modified Epley | 4 wk/6 wk | ||
| Ribeiro et al32 | Randomized controlled trial | 7 (5/2) | PC | 71.75 ± 3.15 | Epley | 1 wk/5 wk/ 9 wk/13 wk |
||
| Roberts et al33 | Case-control | 15 (10/5) | PC | 55.6 ± 9.8 | 15 (7/8) | 48.5 ± 9.8 | ||
| Maslovara et al50 | Prospective clinical trial | 81 (59/22) | PC (79) LC (2) |
60.1 ± 12.1 | Epley BBQ |
1 wk after cure | ||
| Silva et al34 | Prospective, quasi-experimental | 14 (11/3) | PC | 71 ± 4.05 | Epley | 1 wk | ||
| Vaz et al35 | Prospective clinical | 30 (28/2) | PC | 70.10 ± 7.00 | Modified Epley | 1 wk | ||
| Zhang et al36 | Prospective | 27 (16/11) | PC | 56.5 ± 13.1 | 27 (21/6) | 56.1 ± 10.8 | ||
| Zur et al37 | Prospective | 11 | PC | 83 ± 5 | 60 | 83 ± 5 | ||
Abbreviations: AC, anterior semicircular canal BPPV; BBQ, barbeque roll maneuver; BPPV, benign paroxysmal positional vertigo; F, female; LC, lateral semicircular canal BPPV; M, male; PC, posterior semicircular canal BPPV; PRM, particle repositioning maneuver; SD, standard deviation.